Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1952;6:193-200

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SCHWARTZ, S. P.
Right arrow Articles by IMPERIALLI, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCHWARTZ, S. P.
Right arrow Articles by IMPERIALLI, A.

(Circulation. 1952;6:193.)
© 1952 American Heart Association, Inc.


Transient Ventricular Fibrillation

IV. The Effects of Procaine Amide on Patients with Transient Ventricular Fibrillation during Established Auriculoventricular Dissociation

SIDNEY P. SCHWARTZ M.D.1; LEONARD HALLINGER M.D.1; ANTHONY IMPERIALLI M.D.1

1 From the Medical Divisions of the Montefiore and Morrisania Hospitals, New York City.

Procaine amide was given intravenously to three patients with transient ventricular fibrillation during established auriculoventricular dissociation at a time when they were free from symptoms as well as during the attacks. It was determined that this drug has a transitory slowing effect upon the auricles. It depresses rhythmicity in the auriculoventricular node, prolongs the refractory period of the ventricles, results in intraventricular conduction disturbance and the development of premature beats of the ventricles followed by the various forms of ventricular acceleration leading to ventricular fibrillation. Because of these alterations in heart rhythms, procaine amide is contraindicated in the treatment of such patients.